Cereus Biosciences
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Cereus Biosciences operates in Healthcare & Life Sciences and is based in Paris. It was founded in 2023.
Cereus Biosciences is a biotechnology company that develops universal, off-the-shelf cancer vaccines by exploring the dark genome to identify shared tumor-specific neoantigens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cereus Biosciences Comparables
Compare Cereus Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nouscom | 77% |
For institutional investors. Book with your work email.
Cereus Biosciences Funding Rounds
Historical fundraising activity
Cereus Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elaia Partners | Accelerator |
| Paris-Saclay Cancer Cluster | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 344% MoM to 2.3K.
For institutional investors. Book with your work email.
Cereus Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cereus Biosciences's valuation, stock price, and market status.
Is Cereus Biosciences a public or private company?
Cereus Biosciences is a private company.
What is the current stock price of Cereus Biosciences?
Cereus Biosciences is a private company, so its shares have no public market price. Caplight tracks Cereus Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cereus Biosciences worth (valuation)?
Valuation information for Cereus Biosciences is not publicly available.
Can I buy Cereus Biosciences stock?
Cereus Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cereus Biosciences's last funding round?
Funding round information for Cereus Biosciences is not publicly available.
Who are the main investors in Cereus Biosciences?
Key investors in Cereus Biosciences include Elaia Partners, Paris-Saclay Cancer Cluster.
Will Cereus Biosciences IPO soon?
No public IPO plans have been announced for Cereus Biosciences.
How can I track Cereus Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Cereus Biosciences's shares on secondary markets.